Mounjaro’s Meteoric Rise: How Eli Lilly’s Weight-Loss Drug Became India’s Top-Selling Therapy by Value
Eli Lilly’s injectable weight-loss drug Mounjaro has rapidly overtaken established pharmaceuticals in India’s competitive market, emerging as the country’s top-selling drug by value in October 2025. The milestone reflects a seismic shift in healthcare priorities among Indian consumers and doctors, where chronic diseases and body-weight management have become central medical and social concerns. Mounjaro’s rise…









